RxDoctor Payments Data

Mark Agius

Neurology · Woodland, CANPI 1003897349

Payments from drug & device makers

$254,398in general payments, 2019–2025

Across 279 payments — averaging $911.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$110K
  • EMD Serono, Inc.$81K
  • Novartis$34K
  • Genentech USA, Inc.$17K
  • AstraZeneca$12K
  • Biogen$102

What the payments were for

  • Consulting fees$8,2433%
  • Speaking & faculty fees$201,11379%
  • Travel & lodging$38,52715%
  • Food & beverage$6,5153%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi95$109,923
EMD Serono, Inc.113$80,706
Novartis39$33,933
Genentech USA, Inc.14$17,496
AstraZeneca17$12,237
Biogen1$102

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$254,398 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.

See all neurology providers in California

Other neurology in Woodland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →